Put It on the Board, 10/13

Create PDF

Life Tech releases EZQC Online

Life Technologies has launched its EZQC Online, a Web-based tool for quality control management in molecular diagnostic labs. EZQC Online contains three modules: a guidance tool for initial validation and verification of molecular tests, a tool to help labs meet CLIA standards for calibration verification, and a tool for ongoing QC monitoring that provides an opportunity for peer-to-peer comparisons.

The Validations/Verifications module includes a comprehensive database of guidelines and templates that can be used to design validation protocols and analytical reports. The tool’s QC Monitoring module allows labs to monitor test performance, alerting personnel to data drift and to potential failures before they occur. In addition to tracking internal lab testing quality, the online tool offers a feature through which labs can gauge the performance of their assays against that of other laboratories. The data are anonymized, and each user sets the levels of data sharing to ensure confidentiality of results.

Beckman’s AccuTnI+3 cleared for use on UniCel DxI series

The Food and Drug Administration has cleared Beckman Coulter’s Access AccuTnI+3 troponin I assay for use on the UniCel DxI series of immunoassay systems.

The Access AccuTnI+3 troponin I assay was cleared in June for use on Beckman’s Access 2 immunoassay analyzer. The new troponin assay is now cleared for use on all of the company’s immunoassay systems, as well as the UniCel DxC integrated chemistry and immunoassay series.

Dako, Omnyx launch digital solution

Dako and Omnyx LLC, a joint venture of GE Healthcare and the University of Pittsburgh Medical Center, are launching clinical image analysis for digital pathology in Europe.

As part of the collaboration which began in 2010, Dako has used its expertise in staining and image analysis to develop algorithms that are incorporated into the Omnyx digital pathology platform as part of Omnyx’s overall strategy of providing pathologists with a comprehensive digital workflow. The HercepTest image analysis tool is now accessible in the Omnyx system and has been customized for Dako’s breast cancer prognostic markers.